HABA Laboratories,Inc. (TYO:4925)
Japan
· Delayed Price · Currency is JPY 1,805.00
-20.00 (-1.10%)
Mar 10, 2026, 3:03 PM JST
HABA Laboratories,Inc. Revenue
HABA Laboratories,Inc. had revenue of 3.17B JPY in the quarter ending December 31, 2025, with 0.44% growth. This brings the company's revenue in the last twelve months to 12.17B, down -1.04% year-over-year. In the fiscal year ending March 31, 2025, HABA Laboratories,Inc. had annual revenue of 12.06B, down -2.13%.
Revenue (ttm)
12.17B
Revenue Growth
-1.04%
P/S Ratio
0.57
Revenue / Employee
21.43M
Employees
568
Market Cap
6.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.06B | -263.00M | -2.13% |
| Mar 31, 2024 | 12.32B | 286.00M | 2.38% |
| Mar 31, 2023 | 12.04B | -870.00M | -6.74% |
| Mar 31, 2022 | 12.91B | -1.40B | -9.78% |
| Mar 31, 2021 | 14.31B | -4.06B | -22.11% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sagami Rubber Industries | 5.79B |
| Adjuvant Holdings | 3.97B |
| Premier Anti-Aging | 15.57B |
| Almado | 10.18B |
| C'BON COSMETICS | 9.22B |
| AXXZIA | 14.03B |
| Liberta | 10.03B |
| Axas Holdings | 12.45B |